The Liver Meeting 2021-Clinical Hepatology Debrief

Video Transcription

Video Summary

Dr Elizabeth Verna from Columbia University presented at the ASLD meeting on various topics in clinical hepatology. She highlighted new research in chronic liver diseases, specifically alcohol-related liver disease and alcohol use patterns impacting fibrosis. Studies on medical alcohol therapies showed promising results in preventing alcohol-related liver disease and decompensation. Other studies looked at lactobacillus, FMT, antibiotics, and new therapies for Wilson's disease and hemochromatosis. Updates on cholestatic liver diseases and PBC treatments, HCC screening, liver cancer biomarkers, disparities in cirrhosis outcomes, and innovative care models were also discussed. Data on liver transplant for ACLF, allocation changes, and outcomes were shared. COVID-related studies covered long-term impacts, vaccine hesitancy, responses in cirrhosis patients, post-transplant COVID outcomes, and vaccine efficacy. Provider burnout was also addressed, highlighting the challenges faced and recommendations for support. Overall, the meeting showcased a wealth of research advancing our understanding and treatments for liver diseases despite the challenging times.

Keywords

clinical hepatology

alcohol-related liver disease

fibrosis

lactobacillus

Wilson's disease

cholestatic liver diseases

liver transplant